Renalytix (RENX) Stock Chart & Stock Price History GBX 7.13 -0.12 (-1.70%) As of 12:04 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Renalytix Stock Price Performance The Renalytix (RENX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.60%, with a year-to-date return of -35.21%. In the past month, the stock has decreased 1.01%, reflecting recent market activity. As of the latest close, Renalytix traded at GBX 7.13 with a market cap of £29.54 million and volume of 39,751 shares. Five years ago, the stock traded at GBX 572.50, representing a 98.76% decrease over that period. At the time, it had a market cap of £403.13 million and a volume of 291,146 shares. Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.81%1 Month Performance-1.01%3 Month Performance-15.15%Year-To-Date Performance-35.21%1 Year Performance-45.60%5 Year Performance-98.76% RENX Stock Chart for Friday, July, 25, 2025 RENX Chart by TradingView Renalytix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025GBX 7.50GBX 7.13-4.97%GBX 7.13GBX 739,751 shs£29.54 million07/23/2025GBX 7.13GBX 7.50+5.26%GBX 7.50GBX 739,823 shs£31.09 million07/22/2025GBX 7.50GBX 7.13-5.00%GBX 7.25GBX 7.1361,853 shs£29.54 million07/21/2025GBX 7GBX 7.50+7.14%GBX 7.50GBX 7.10150,085 shs£31.09 million07/18/2025GBX 7.35GBX 7-4.76%GBX 8GBX 7153,221 shs£29.02 million07/17/2025GBX 6.80GBX 7.35+8.09%GBX 7.70GBX 7.01877,131 shs£30.47 million07/16/2025GBX 6.65GBX 6.80+2.26%GBX 6.80GBX 6.55538,448 shs£28.19 million07/15/2025GBX 6.85GBX 6.65-2.92%GBX 7GBX 6.60414,701 shs£27.57 million07/14/2025GBX 7.50GBX 6.85-8.67%GBX 7.50GBX 6.757,170 shs£28.40 million07/11/2025GBX 6.75GBX 7.50+11.11%GBX 7.50GBX 6.501,548 shs£31.09 million Get the Latest News and Ratings for RENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025GBX 6.90GBX 6.75-2.17%GBX 7.50GBX 6.7344,375 shs£27.98 million07/09/2025GBX 6.90GBX 6.90GBX 7.50GBX 6.50239,998 shs£28.60 million07/08/2025GBX 6.68GBX 6.90+3.29%GBX 7GBX 6.68131,781 shs£28.60 million07/07/2025GBX 7GBX 6.68-4.57%GBX 7.50GBX 6.50110,339 shs£27.69 million07/04/2025GBX 7GBX 7GBX 7.50GBX 6.70657,907 shs£29.01 million07/03/2025GBX 6.70GBX 7+4.46%GBX 7.50GBX 6.70657,907 shs£29.01 million07/02/2025GBX 6.85GBX 6.70-2.19%GBX 7.50GBX 6.70777,493 shs£27.77 million07/01/2025GBX 7.01GBX 6.85-2.21%GBX 7.50GBX 6.66209,527 shs£28.40 million06/30/2025GBX 7.20GBX 7.01-2.71%GBX 7.25GBX 7120,635 shs£29.04 million06/27/2025GBX 7.20GBX 7.20GBX 7.22GBX 7.0133,990 shs£29.85 million06/26/2025GBX 7.20GBX 7.20GBX 7.20GBX 7.013,036 shs£29.85 million06/25/2025GBX 7.22GBX 7.20-0.28%GBX 7.50GBX 718,625 shs£29.85 million06/24/2025GBX 7.50GBX 7.22-3.73%GBX 7.50GBX 7125,638 shs£29.93 million Related Companies Kooth Stock Chart Cambridge Cognition Stock Chart Induction Healthcare Group Stock Chart Feedback Stock Chart IQ-AI Stock Chart Trellus Health Stock Chart Craneware Stock Chart Ondine Biomedical Stock Chart Diaceutics Stock Chart Scancell Stock Chart Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. This page (LON:RENX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
